Navigation Links
Metamark Genetics Announces Cancer Cell Study Highlighting Discovery of Key Molecules that Drive Progression of Malignant Melanoma in Humans
Date:7/11/2011

ncer research and demonstrated to play a causal role in promoting tumor progression and spread. For further information, please visit the company's website at www.metamarkgenetics.com.

Cautionary Note Regarding Forward-Looking Statements

This press release, and information contained on Metamark's website, contains forward-looking statements that involve substantial risks and uncertainties, including statements regarding Metamark's strategies and future plans, prospects and results, are forward-looking statements. The words "anticipate," "believe," "expect," "intend," "may," "plan," and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.  Metamark may not actually achieve the plans or expectations disclosed in its forward-looking statements, and you should not place undue reliance on its forward-looking statements.


'/>"/>
SOURCE Metamark Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics
2. Signal Genetics and DiagnoCure Announce a US$13.3M Collaboration for the Commercialization of Previstage™ GCC Colorectal Cancer Staging Test
3. Research 2.0 Updates Coverage of Viral Genetics with Research Report Focused on VG Energy
4. Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs
5. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
6. USP Hospitales of Spain to Offer Interleukin Genetics Heart Health Test Throughout Its Hospital Network
7. Interleukin Genetics and Metagenics Initiate Research Collaboration
8. Technology Collaboration Between New England Biolabs and Sequenom Delivers First Product for Epigenetics
9. LABS, Inc. Announces Alliance with Ambry Genetics to Expand Testing Solutions for the Reproductive Health Industry
10. RainDance Technologies and Ambry Genetics Expand Collaboration to Address ADME Analysis
11. JS Genetics Develops New Non-Invasive Test, XCAT-TS, to Help Doctors Diagnose Turner Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 The Assistance Fund ... This program provides financial assistance for copay to individuals ... to announce the addition of the Melanoma Copay Assistance ... Mark McGreevy , executive director. "With each additional program ... of a world where no one is denied access ...
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage ... regeneration, today announced that J.J. Finkelstein , chief ... corporate overview at two upcoming investor conferences. ... th Annual Microcap Conference on Thursday May 28, ... at 11:00 am EDT.  A webcast will be available ...
(Date:5/22/2015)... May 22, 2015  The Mesothelioma Victims Center ... of mesothelioma get the best possible compensation, and they ... with this rare cancer caused by exposure to ... information related to treatment options such as a ... the Mesothelioma Victims Center anytime at 866-714-6466. ...
Breaking Medicine Technology:The Assistance Fund Adds Melanoma Assistance Program 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
... 5, 2007 - Synta,Pharmaceuticals Corp., (NASDAQ: SNTA) ... commercializing small,molecule drugs to treat severe medical ... of overall survival (OS) time,for patients in ... clinical trial in metastatic melanoma for its,lead ...
... 5, 2007 - Gloucester,Pharmaceuticals, Inc., a privately held ... romidepsin as a,treatment for cutaneous T-cell lymphoma (CTCL) ... American Society of,Clinical Oncology (ASCO) Annual Meeting being ... of an interim analysis of a phase II,study ...
Cached Medicine Technology:Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 2Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 3Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 4Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 5Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 6Synta Presents Results for STA-4783 in Metastatic Melanoma Showing,Improvement in Overall Survival 7Gloucester Pharmaceuticals Reports Positive Interim Phase II Data,on Romidepsin for T-Cell Lymphomas at the 2007 American Society of,Clinical Oncology Annual Meeting 2Gloucester Pharmaceuticals Reports Positive Interim Phase II Data,on Romidepsin for T-Cell Lymphomas at the 2007 American Society of,Clinical Oncology Annual Meeting 3
(Date:5/23/2015)... CO (PRWEB) May 23, 2015 On May ... in MuckFest. The event was a 5k mud obstacle run ... more than 2 million people worldwide, and the reason we ... community,” said Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred ... Multiple Sclerosis Society.” , The event was not only attended ...
(Date:5/23/2015)... 2015 A live auction will be held ... surgery centers and other medical facilities around the United States. ... lab, radiology, surgery, anesthesia, exam and much more. , ... Thursday, May 28 starting at 9:00am CDT each day. The ... 25th Avenue, Melrose Park, IL 60160. Anyone can participate ...
(Date:5/23/2015)... Viejo, CA (PRWEB) May 23, 2015 Add ... from Pixel Film Studios. , It's as simple as ... as utilizing the included tool for full effect. , ... filmed on high-dynamic range 5k sensors making this the ultimate ... The prismatic flares included in this package are movie files ...
(Date:5/22/2015)... Pasadena, Calif. (PRWEB) May 22, 2015 ... where technology, communication and capacity are intersecting to ... and across society, the opening speaker at WesternU's ... , California Lieut. Gov. Gavin Newsom, a former ... was the keynote speaker at the graduation ceremony ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 The American ... exciting events in June. They will hold a webinar ... and a two-day class on Classical Chinese Medicine. , ... 3, Dr. Steve Given, the Dean of Clinical Education, ... the new First Professional Doctorate program. ACTCM is currently ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:ACTCM Announces Upcoming June Events 2
... kids, take some precautions, expert says , SATURDAY, ... summer camp, many parents are concerned about the risk for ... when they,re at camp, Dr. Jeffrey Boscamp, a pediatric infectious ... recommends the following: , , Confirm that the camp is ...
... ... its annual Asia/Pacific distributor training program in Suzhou, China, with over 60 representatives in ... Torrance, ... in Suzhou, China, with over 60 representatives in attendance., , ,This year,s training was ...
... TIJUANA, Mexico, July 17 The following press release is being ... which occurred in Hermosillo, Mexico, where 40+ children perished in a ... a war against childcare facility owners throughout Mexico. , ... corrupt politicians, drug lords and the underworld, has now thrown childcare ...
... , , THOUSAND OAKS, ... today announced the U.S. Food and Drug Administration (FDA) has approved ... receptor (EGFr) class of antibodies, including Vectibix((R)) (panitumumab). This decision follows ... the clinical utility of the KRAS gene as a ...
... , , WASHINGTON, ... is calling on all health care reform stakeholders to revisit cost issues ... , "Especially given the Congressional Budget Office,s ... to establish mutual understanding as to what will lead to real and ...
... , , , ... NGSX ) announced today that Bruce A. Peacock has resigned from ... responsibilities as CEO of privately-held Alba Therapeutics. , ... time to resign, I feel confident that NeurogesX is well positioned following ...
Cached Medicine News:Health News:iCRco Conducts 2009 Asia/Pacific Distributor Training Program 2Health News:iCRco Conducts 2009 Asia/Pacific Distributor Training Program 3Health News:Tijuana Newspaper, Zeta Tijuana, Releases Detailed List of Day Care Center Owners and Their Total Earnings; Interchildren, Inc. Calls for Newspaper Boycott 2Health News:Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab) 2Health News:Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab) 3Health News:Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab) 4Health News:Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab) 5Health News:Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab) 6Health News:Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab) 7Health News:Actuaries: Health Care Reform Must Address Costs 2Health News:NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors 2Health News:NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors 3Health News:NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors 4
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: